Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis

Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis

Pediatric germ cell tumors (GCTs) are a group of chemosensitive malignancies with a 90% curability rate. We report a series of children with relapsing or therapy-resistant GCT treated with melphalan–etoposide–carboplatin high-dose chemotherapy (HDCT) and autologous stem cell transplantation. This co...

Full description

Bibliographic Details
Main Authors:	Marek Ussowicz, Monika Mielcarek-Siedziuk, Jakub Musiał, Mateusz Stachowiak, Jadwiga Węcławek-Tompol, Dorota Sęga-Pondel, Jowita Frączkiewicz, Joanna Trelińska, Anna Raciborska
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Cancers
Subjects:	germ cell tumors high dose chemotherapy autologous stem cell transplantation
Online Access:	https://www.mdpi.com/2072-6694/12/12/3841

Similar Items

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
by: Tricia Tay, et al.
Published: (2022-09-01)

First hematopoietic stem cell transplantation in a child with late infantile Krabbe disease in Poland
by: Izabella Miśkiewicz-Migoń, et al.
Published: (2021-03-01)

The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder
by: Zofia Szmit, et al.
Published: (2022-09-01)

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
by: Rei Kamitani, et al.
Published: (2022-11-01)

BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
by: Ran Wu, et al.
Published: (2023-06-01)

Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient
by: Zhe Huang, et al.
Published: (2023-03-01)

Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status
by: Nobuaki Mamesaya, et al.
Published: (2023-03-01)

Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer
by: Soo Han Kim, et al.
Published: (2023-03-01)

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer
by: Ayako Shiono, et al.
Published: (2023-01-01)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
by: Masayuki Imaya, et al.
Published: (2022-05-01)

Small-cell neuroendocrine tumor of the bladder: Unexpected long-term survival with carboplatin-etoposide therapy in a patient with metastatic stage disease
by: Eduardo J García Rico, et al.
Published: (2023-01-01)

Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab
by: Reyes Bernabé, et al.
Published: (2024-01-01)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
by: Valiollah Mehrzad, et al.
Published: (2017-01-01)

The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”
by: Ali Eser, et al.
Published: (2021-05-01)

Evaluating the Efficacy of Modified BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country
by: Mani Ramzi, et al.
Published: (2023-04-01)

Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia
by: Małgorzata Salamonowicz-Bodzioch, et al.
Published: (2021-09-01)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
by: Satoshi Wasamoto, et al.
Published: (2023-01-01)

Efficacy and Safety of Anti–Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial
by: Shun Lu, PhD, MD, et al.
Published: (2023-04-01)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
by: Junko Johansson, et al.
Published: (2018-12-01)

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
by: Jérémy Baude, et al.
Published: (2024-01-01)

Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma
by: Ahmed Mahdy, et al.
Published: (2023-06-01)

MELPHALAN-INDUCED CYTOTOXICITY IN THE BONE MARROW OF RATS BY FLOW CYTOMETRY MEASUREMENTS
by: B I. Gerashchenko, et al.
Published: (2019-03-01)

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option Worth Consideration for High Disease Burden
by: Paweł Marschollek, et al.
Published: (2022-11-01)

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells
by: Anastazja Poczta, et al.
Published: (2022-02-01)

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.
by: Daniele Avenoso, et al.
Published: (2023-06-01)

Hypoxia Promotes Angiogenic Effect in Extracranial Arteriovenous Malformation Endothelial Cells
by: Joon Seok Lee, et al.
Published: (2022-08-01)

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol
by: Tetsuhiko Asao, et al.
Published: (2022-11-01)

Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin
by: Niclas Björn, et al.
Published: (2020-05-01)

Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells
by: Magdalena Kluska, et al.
Published: (2021-03-01)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023-01-01)

Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group
by: Reza Safaee, et al.
Published: (2012-07-01)

PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE
by: S. Di Folca, et al.
Published: (2022-06-01)

Evaluation of gastrointestinal complications in Egyptian patients after autologous stem cell transplantation using melphalan-based regimens
by: Mona Mahrous Abdelaty, et al.
Published: (2023-04-01)

Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report
by: Víctor Alía Navarro, et al.
Published: (2023-09-01)

Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma
by: Aimee Merino, et al.
Published: (2024-03-01)

The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin
by: Ekaterina Pashkina, et al.
Published: (2021-07-01)

Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation
by: Chong-Zhi Lew, et al.
Published: (2023-03-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Encephalopathy complicating high-dose melphalan.
by: Schuh, A, et al.
Published: (1999)